Several years ago, the United States Preventive Services Task Force (USPSTF) recommended against men over the age of 75 having prostate cancer screenings using the PSA (prostate-specific antigen) test.

Being diagnosed with any cancer makes you think about your life - and death. The course of prostate cancer, though, may be changing.

Prostate cancer screening guidelines have been changing over the past several years. All of this is thanks to the advice of United States Preventative Services Task Force (USPSTF). 

If you've been following the news about prostate cancer, you know a great deal of caution has been injected into the conversation. A new study shows that a conservative approach to the disease is quite valid.

A great deal of cancer medicine has to do with targeting and then blocking the activities of molecules that create chaos - and cancer - in the body.

The chemotherapy used to treat prostate cancer is no picnic. A new option is emerging that could combine the powers of tea and gold.

Radiation therapy is often used at some point in treating prostate cancer. A recently published study finds that a combination of radiation therapies may be an effective treatment option that decreases problematic side effects.

There has been a dizzying amount of information lately about using prostate-specific antigen (PSA) testing to screen for prostate cancer.

Not only is prostate cancer tough, the toll it takes on sexual function doesn’t make things any easier. A little support from peers and professionals can help.

The current most widely used test for detecting and monitoring prostate cancer, known as prostate specific antigen (PSA), has a lot of room for improvement for detecting new cancers.